Bristol Myers gains after Leerink Partners raises PT on stroke drug optimism
ReutersNov 24, 2025 10:47 AM
Shares of drugmaker Bristol Myers Squibb BMY.N rise 3.9% to $48.03 premarket
Brokerage Leerink Partners raises PT to $54 from $53, sees positive readthrough from Bayer’s stroke trial
Bayer BAYGn.DE says oral blood thinner met main goals of late-stage study, boosting confidence in BMY’s experimental drug milvexian
Milvexian is being tested for preventing repeat strokes and irregular heartbeat; results expected late 2026 - Leerink
Brokerage raises success odds for stroke use to 80%, lifts 2032 risk-adjusted sales forecast to $3.1 bln
Seven of 29 brokerages rate the stock "buy" or higher, 20 "hold", 2 "sell"; median PT is $52 - data compiled by LSEG
Up to last close, BMY shares down ~18% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital baTradingKey
23 hours ago
Cathie Wood Predicts Bitcoin Has Bottomed. Is Now The Best Time to Buy? How to Buy BTC?
Purchasing Bitcoin is generally divided into three stages: pre-transaction, during transaction, and post-transaction. Each stage requires careful attention, as losses can easily arise from operational errors, pitfalls, and other factors.TradingKey
Fri, Dec 19
Japan Central Bank Rate Hike To Three-Decade High Imminent, How Will The Market Go? Which Assets Most Affected?
As global monetary policy divergence enters a critical phase, the Bank of Japan (BoJ) is anticipated to raise its benchmark interest rate at the monetary policy meeting on December 19, 2025, by 25 basis points to 0.75% , marking its highest level in nearly 30 years.TradingKey
Thu, Dec 18
Gold Price Steady Climb and the Sudden Surge of Silver and Copper: Will Their Bull Run Extend Into 2026?
Dow Jones Market Data shows this marks the first time since 1980all three metals—gold, silver, and copper—simultaneously refreshed their all-time highs in the same year. Will this rally extend into 2026?TradingKey
Wed, Dec 10
Tradingkey
